how long have glp-1 drugs been on the market Poll: 1 in 8 Adults Say They Are Currently Taking a Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say Are Difficult to Afford History of GLP-1 Medications -

Front Psychiatry 2022;13:813304

The peptide works by modulating beta-3 adrenergic receptors and directly interacting with fat cells to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (new fat formation)

Nat Rev Cancer 16 , 345358 (2016)

By using senolytics to remove senescent endothelial and smooth muscle cells, combined with senomorphics like rapamycin to modulate the SASP, this dual approach could reduce arterial stiffness, improve vascular function, and lower the risk of heart attacks and stroke

Manufacturers often claim high C ratings for their products, but they sometimes inflate these numbers, which dont reflect real-world performance